Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum.

Betapapillomavirus (betaPV) DNA and seroresponses are highly prevalent in the general population and both are frequently used as infection markers in epidemiological studies to elucidate an association with cutaneous squamous cell carcinoma (SCC). Little is known about the natural history of betaPV infection and the aspects of infection that drive antibody responses. To investigate the relationship between these markers, this study assessed whether the presence or persistence of betaPV DNA in eyebrow hairs and L1 antibodies of the same betaPV type co-occurred more frequently than would be expected by chance in both a cross-sectional assessment and a longitudinal study. betaPV DNA in plucked eyebrow hairs and L1 antibodies in serum were measured in 416 participants of the Australian community-based Nambour Skin Cancer Study in 1996. Similar data were available for a subset of 148 participants in 2003. Observed co-occurrence of betaPV DNA and antibodies was compared with expected values based on prevalence. A case-wise concordance index was used to calculate the overall concordance of betaPV DNA and antibodies of the same type. No significant associations were found between the presence or persistence of betaPV DNA and antibody responses. The age and sex of the host did not influence the association, and nor did SCC status or a history of sunburns. It was concluded that betaPV antibody responses in adults are not primarily driven by betaPV infection as measured in eyebrow hairs. Other factors, such as viral load, may play a more pivotal role in the induction of detectable seroresponses.

[1]  W. Quint,et al.  Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell‐carcinoma patients , 2010, International journal of cancer.

[2]  W. Quint,et al.  Persistence of betapapillomavirus infections as a risk factor for actinic keratoses, precursor to cutaneous squamous cell carcinoma. , 2009, Cancer research.

[3]  M. Pawlita,et al.  A case‐control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: The role of antibodies against human papillomavirus and other risk factors , 2009, International journal of cancer.

[4]  E. de Villiers,et al.  Characterization of seven novel human papillomavirus types isolated from cutaneous tissue, but also present in mucosal lesions. , 2009, The Journal of general virology.

[5]  M. Pawlita,et al.  Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. , 2009, The Journal of general virology.

[6]  L. Naldi,et al.  Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. , 2009, The Journal of general virology.

[7]  V. Sondak,et al.  Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers , 2008, International journal of cancer.

[8]  M. Pawlita,et al.  Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin , 2008, The British journal of dermatology.

[9]  M. Pawlita,et al.  Seroprevalence of 34 Human Papillomavirus Types in the German General Population , 2008, PLoS pathogens.

[10]  N. Kiviat,et al.  Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. , 2008, The Journal of investigative dermatology.

[11]  J. Dillner,et al.  Seroreactivity to Cutaneous Human Papillomaviruses among Patients with Nonmelanoma Skin Cancer or Benign Skin Lesions , 2008, Cancer Epidemiology Biomarkers & Prevention.

[12]  T. Key,et al.  A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition , 2007, International journal of cancer.

[13]  A. Green,et al.  Sun-related factors, betapapillomavirus, and actinic keratoses: a prospective study. , 2007, Archives of dermatology.

[14]  S. Franceschi,et al.  Development of a Sensitive and Specific Multiplex PCR Method Combined with DNA Microarray Primer Extension To Detect Betapapillomavirus Types , 2007, Journal of Clinical Microbiology.

[15]  J. J. Tai,et al.  Twin concordances test for ascertained trichotomous traits data , 2007, Statistics in medicine.

[16]  W. Quint,et al.  Evaluation of a Novel Highly Sensitive, Broad-Spectrum PCR-Reverse Hybridization Assay for Detection and Identification of Beta-Papillomavirus DNA , 2006, Journal of Clinical Microbiology.

[17]  M. Karagas,et al.  Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. , 2006, Journal of the National Cancer Institute.

[18]  A. Green,et al.  Markers of Cutaneous Human Papillomavirus Infection in Individuals with Tumor-Free Skin, Actinic Keratoses, and Squamous Cell Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[19]  B. Lloveras,et al.  Development of a General-Primer-PCR-Reverse-Line-Blotting System for Detection of Beta and Gamma Cutaneous Human Papillomaviruses , 2005, Journal of Clinical Microbiology.

[20]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[21]  C. Proby,et al.  Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. , 2005, The Journal of investigative dermatology.

[22]  R. Westendorp,et al.  Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. , 2003, The Journal of investigative dermatology.

[23]  P. Fuchs,et al.  High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population , 2003, Archives of Dermatological Research.

[24]  F. Sera,et al.  Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. , 2003, Archives of dermatology.

[25]  R. Westendorp,et al.  Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. , 2003, Cancer research.

[26]  A. Green,et al.  Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. , 2001, The Journal of investigative dermatology.

[27]  B. Hansson,et al.  The Ubiquity and Impressive Genomic Diversity of Human Skin Papillomaviruses Suggest a Commensalic Nature of These Viruses , 2000, Journal of Virology.

[28]  G. Orth,et al.  Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. , 2000, The Journal of investigative dermatology.

[29]  P. Fuchs,et al.  The presence of antibodies against virus‐like particles of epidermodysplasia verruciformis‐associated humanpapillomavirus type 8 in patients with actinic keratoses , 2000, The British journal of dermatology.

[30]  J. Dillner The serological response to papillomaviruses. , 1999, Seminars in cancer biology.

[31]  H. Hausen Papillomaviruses in human cancers , 1999, Proceedings of the Association of American Physicians.

[32]  Gail M. Williams,et al.  Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial , 1999, The Lancet.

[33]  L Beardsley,et al.  Natural history of cervicovaginal papillomavirus infection in young women. , 1998, The New England journal of medicine.

[34]  J. Bouwes Bavinck,et al.  Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. , 1998, The Journal of investigative dermatology.

[35]  J. Bouwes Bavinck,et al.  Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. , 1997, The Journal of investigative dermatology.

[36]  D. Battistutta,et al.  Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. , 1996, American journal of epidemiology.

[37]  T. Kiyono,et al.  Detection of human papillomavirus (HPV) type 47 DNA in malignant lesions from epidermodysplasia verruciformis by protocols for precise typing of related HPV DNAs , 1996, Journal of clinical microbiology.

[38]  David R. Scott,et al.  Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. , 1995, The Journal of infectious diseases.

[39]  M. Evander,et al.  Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort Study , 1995 .

[40]  David R. Scott,et al.  Persistence of type-specific human papillomavirus infection among cytologically normal women. , 1994, The Journal of infectious diseases.

[41]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[42]  M. Ocké European prospective investigation into cancer and nutrition. Voedingsnavraag in de EPIC studie. , 1996 .

[43]  M. Evander,et al.  Human papillomavirus infection is transient in young women: a population-based cohort study. , 1995, The Journal of infectious diseases.